Joe Newell is the Chief Operations Officer for Atara, overseeing Process Sciences, Manufacturing, Quality, Program Management, Alliance Management, and Enterprise Services. He has extensive experience in product development, operational and quality management, and continuous improvement. Joe is a values-based leader passionate about cross-functional teamwork that results in delivering transformative medicines for patients through his role at Atara.
Prior to joining Atara in 2017 to lead Technical Operations, he served as Vice President, Manufacturing at Alexion Pharmaceuticals, where he was responsible for leading bulk drug substance manufacturing operations across seven facilities in the United States and supporting global expansion efforts in Ireland.
Previously, Joe spent several years at Amgen, where he served in multiple global leadership roles across Manufacturing and Supply Chain. Earlier in his career, he held operational and entrepreneurial leadership roles with Catalent, Cardinal Health, Matrix Pharmaceutical, and Stanford Research Institute (SRI International).
Joe holds a B.S. in biology from California Polytechnic University, Pomona.
Away from work, he is dedicated to his wife and three children and enjoys the outdoors, sports, and a variety of restoration projects.
What is Joe Newell's net worth?
The estimated net worth of Joe Newell is at least $86,106.89 as of August 30th, 2021. Mr. Newell owns 123,045 shares of Atara Biotherapeutics stock worth more than $86,107 as of April 25th. This net worth estimate does not reflect any other investments that Mr. Newell may own. Learn More about Joe Newell's net worth.
How do I contact Joe Newell?
Has Joe Newell been buying or selling shares of Atara Biotherapeutics?
Joe Newell has not been actively trading shares of Atara Biotherapeutics during the past quarter. Most recently, Joe Newell sold 7,000 shares of the business's stock in a transaction on Monday, November 15th. The shares were sold at an average price of $17.71, for a transaction totalling $123,970.00. Learn More on Joe Newell's trading history.
Who are Atara Biotherapeutics' active insiders?
Are insiders buying or selling shares of Atara Biotherapeutics?
During the last year, Atara Biotherapeutics insiders bought shares 2 times. They purchased a total of 279,020 shares worth more than $64,384.40. During the last year, insiders at the biotechnology company sold shares 12 times. They sold a total of 184,801 shares worth more than $237,993.35. The most recent insider tranaction occured on March, 4th when CEO Pascal Touchon sold 24,844 shares worth more than $17,887.68. Insiders at Atara Biotherapeutics own 4.5% of the company.
Learn More about insider trades at Atara Biotherapeutics. Information on this page was last updated on 3/4/2024.
